semaglutide vs dulaglutide Key drivers of clinical differences between once-weekly and Dulaglutide vs. Semaglutide: Differences and

UK regulatory guidance (MHRA, NICE, BNF) advises against GLP-1 use whilst breastfeeding owing to lack of robust human safety studies

T.BeckT.BennettD

Once-Weekly Semaglutide in Adults With Alcohol Use Disorder: A Randomized Clinical Trial

Unlike manufactured pharmaceuticals that may have expiration dates extending several years, compounded medications often have shorter beyond-use dates, typically ranging from thirty to ninety days depending on the specific formulation and storage conditions

In September 2023, FDA placed "Thymosin Beta-4, Fragment (LKKTETQ)," the substance sold as TB-500, on Category 2 of its interim 503A bulk drug substances list, meaning FDA identified significant safety concerns and would not permit licensed compounding pharmacies to use it